Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac ...

Invasive epicardial coronary physiologic assessment is increasingly performed to evaluate the hemodynamic significance of ...

The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.

Catheter Precision (VTAK) announces its third VIVO system installation in France, at the Centre Hospitalier Regional Universitaire Nancy. Led by ...

Caranx Medical ("Caranx"), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving ...

"Expanding access to treatments for diseases that disproportionately impact women, including breast cancer, the most common cancer among women in the US excluding skin cancer, is at the core of our ...

Boston Scientific anticipates that assisting in commercialising Siemens Healthineers’ 4D ICE catheter will pay dividends for ...

Microrobots could be precisely directed, under clinical conditions, by integrating systems for navigation, therapeutic ...

Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on the cardiac electrophysiology marketplace ...

Background: Catheter ablation for ventricular tachycardia (VT) has been increasingly performed. While it is estimated that 42% of adults in the United States are obese, the impact of obesity on VT ...

The small-profile device expands to capture clots like large-bore systems while offering good reduction in RV/LV ratio at 48 hours.

The platform is tailored to convert brain’s neural activity into digital commands, eliminating the need for open-brain ...